Feature | May 18, 2011| Mladen I. Vidovich, M.D., FACC, FSCAI

Radial Angiography and Intervention Abstracts From ACC and i2 Summit

There were 15 abstracts presented describing radial access and intervention during the American College of Cardiology (ACC) and i2 Summit meeting in April in New Orleans. The scientific work was submitted from all over the world - Canada, South Korea, Australia, the former Yugoslav republic of Macedonia, the United States, Italy and Japan. The abstracts focused on some of the most burning issues in current radial research.
Hibbert et al. from Ottawa, Canada nicely demonstrated that morbidly obese patients (BMI ? 40) had fewer bleeding and access site complications compared to femoral approach. Similarly, Jacobs et al. from the University of Miami elegantly demonstrated that in the very challenging patients with end-stage liver disease and associated coagulopathy and thrombocytopenia radial was a feasible and safe.

Unprotected left main is the specialty of the South Korean investigators. Youn and colleagues reported that crossover to femoral from radial was more likely to occur due to underlying coronary anatomical considerations, rather than patients’ clinical disease.

The group from Wake Forest University showed that failed radial access increases cardiac catheterization laboratory utilization and that in patients with failed radial access, bleeding rates do not substantially differ from femoral access.

The very nicely named Italian “Paprica” trial investigators demonstrated lower rates of short-term mortality with radial access, primarily due to reduction in major bleeding. A Japanese group from tsunami-affected city of Miyagi described very convincingly the safety and efficacy of a 7.5 French sheathless system for complex PCI with a somewhat difficult-to-reconcile zero percent radial occlusion rate. These findings are important, as they demonstrate that large equipment can safely be used with radial approach, particularly if performed in the overall smaller body habitus Japanese population.

Several abstracts tackled the predictors of procedural difficulty in obtaining radial access (newly described in this abstract - Hispanic origin). Sandeep Nathan, M.D., MS, from the University of Chicago, reported very high rates of radial atherosclerosis in a single center (32 percent). Whether transradial PCI is appropriate for STEMI was confirmed by Rha et al. from Seoul – they observed lower in-hospital and six-month cardiac death with transradial PCI when compared to femoral access. The group from Skopje in the former Yugoslav republic of Macedonia reported a non-randomized series of nearly 1,700 ST-elevated myocardial infarction (STEMI) patients treated with femoral (60 percent) and radial access (40 percent). Likely due to selection bias, the transfemoral group had higher mortality and more patients presented with cardiogenic shock. Nonetheless, procedural times were similar with lower access site complications with radial approach. Similarly, Malaipan from Melbourne, Australia, reported that recommended door-to-balloon (D2B) times are achievable with utilization of radial approach in STEMI.

In summary, it is clear that transradial PCI is a global phenomenon. Great minds think alike and it is very encouraging to observe parallel progress in this field on almost all the continents.

Related Content

Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Clinical Study | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Clinical Study | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Clinical Study | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Clinical Study | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Clinical Study | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Clinical Study | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Clinical Study | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init